Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Among authors: van klaveren rj, van meerbeeck jp. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP, Baas P, Debruyne C, Smit EF, van Klaveren RJ, Galdermans D, Lentz MA, Manegold C, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Eur J Cancer. 2002 Apr;38(6):779-83. doi: 10.1016/s0959-8049(01)00428-2. Eur J Cancer. 2002. PMID: 11937311 Clinical Trial.
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.
Surmont V, Aerts JG, van Klaveren RJ, Tournoy K, Tan KY, Vernhout RM, Schmitz PI, Legrand C, Hoogsteden HC, van Meerbeeck JP. Surmont V, et al. Among authors: van klaveren rj, van meerbeeck jp. Oncology. 2010;78(3-4):267-70. doi: 10.1159/000315733. Epub 2010 Jun 7. Oncology. 2010. PMID: 20523087 Free article. Clinical Trial.
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
Surmont V, Smit EF, de Jonge M, Aerts JG, Nackaerts K, Vernhout R, Gras J, Van Wijk A, Phernambucq EC, van Meerbeeck JP, Senan S, Kraaij CJ, Chouaki N, Praag J, van Klaveren RJ. Surmont V, et al. Among authors: van klaveren rj, van meerbeeck jp, van wijk a. Lung Cancer. 2010 Sep;69(3):302-6. doi: 10.1016/j.lungcan.2009.12.001. Epub 2010 Jan 22. Lung Cancer. 2010. PMID: 20096951 Clinical Trial.
Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer.
Surmont V, van Klaveren RJ, Goor C, Schramel F, Manegold C, Legrand C, Van Schil P, Van Meerbeeck JP. Surmont V, et al. Among authors: van klaveren rj, van meerbeeck jp, van schil p. Lung Cancer. 2007 Jan;55(1):95-9. doi: 10.1016/j.lungcan.2006.09.015. Epub 2006 Oct 27. Lung Cancer. 2007. PMID: 17069931
Chemotherapy for non-small-cell lung cancer.
van Meerbeeck JP, Legrand C, van Klaveren RJ, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Lancet. 2001 Oct 13;358(9289):1271-2. doi: 10.1016/S0140-6736(01)06363-2. Lancet. 2001. PMID: 11675091 No abstract available.
Prognostic factors in non-small cell lung cancer surgery.
Birim O, Kappetein AP, van Klaveren RJ, Bogers AJ. Birim O, et al. Among authors: van klaveren rj. Eur J Surg Oncol. 2006 Feb;32(1):12-23. doi: 10.1016/j.ejso.2005.10.001. Epub 2005 Nov 16. Eur J Surg Oncol. 2006. PMID: 16297591 Review.
Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.
Nuyttens JJ, van der Voort van Zyp NC, Verhoef C, Maat A, van Klaveren RJ, van der Holt B, Aerts J, Hoogeman M. Nuyttens JJ, et al. Among authors: van klaveren rj. Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):337-43. doi: 10.1016/j.ijrobp.2014.10.021. Int J Radiat Oncol Biol Phys. 2015. PMID: 25636758 Clinical Trial.
119 results